Tag: Healthcare access

While nearly 1 in 8 American adults reported trying a GLP-1 drug like Ozempic, according to 2024 data from the Kaiser Family Foundation, the viral question, 'What city is everyone on Ozempic?' is based more on media hype than reality. A closer look at prescription data reveals a surprising contender for the highest concentration of users, far removed from the celebrity hotspots typically associated with the drug.

According to a 2024 IQVIA report, 98 million new therapy prescriptions were abandoned by patients in 2023, highlighting a pervasive and costly healthcare problem. This phenomenon, often driven by a variety of systemic and personal factors, begs the question: what is drug abandonment?.